Decisional conflict among patients with prostate cancer considering germline testing
BACKGROUND: Decisional conflict has not been well characterized in patients with prostate cancer (PCa) considering germline testing. Understanding variations in decisional conflict may explain disparities in germline testing uptake. METHODS: A prospective study of patients with PCa seen at a hybrid oncology/genetics "genetic testing station" (GTS) was conducted. After pre-test counseling from the referring oncologist and video education facilitated by a genetic counseling assistant, presence/absence of patient-reported decisional conflict was assessed using the SURE Test. Patient clinical and demographic data were collected from the electronic health record. Chi-squared tests and univariable logistic regressions were conducted to determine the association of decisional conflict with clinical and demographic factors. RESULTS: Of 853 eligible patients approached, 650 (76%) patients completed the decisional conflict instrument. Sixty (9%) patients experienced decisional conflict. No factors, including race, were associated with decisional conflict. CONCLUSIONS: Decisional conflict was uncommon and similar across subgroups. GTS may be a model to deliver high-volume, equitable pre-test genetic counseling and decision support. Further research is needed to understand sources of disparities in germline testing uptake.
Authors
- Amie M Blanco (ORCID: https://orcid.org/0000-0003-3690-0038)
- Kelly M. Gordon (ORCID: https://orcid.org/0000-0002-5862-7055)
- Barry Tong (ORCID: https://orcid.org/0000-0003-3433-7296)
- Daniel Hyuck-Min Kwon (ORCID: https://orcid.org/0000-0002-0830-7918)
- Liam Gima-Lange
Institutions
- University of California, San Francisco (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- University of San Francisco (US)
Publication Details
- Journal
- Hereditary Cancer in Clinical Practice
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1186/s13053-026-00366-7
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00